It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Delve into Value Oriented Index Funds For Retirement Planning to prioritize cost-effective exposure. Find funds that suit your planning horizon.
24,519 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Global AI capital expenditure is approaching 3% of GDP, lifting corporate earnings and driving a momentum-led rally d...
AI-driven models flag XRP as the most likely to post the biggest gains in the second half of 2026, even as Bitcoin an...
A New York Federal Reserve study finds engineering majors lead the early- career pay pack, with computer engineering ...
A July 12 KBW report argues artificial intelligence will fortify the industry’s largest lenders rather than upend the...
As Tesla prepares for its July 22 report, investors are focused on margin expansion, software and services momentum, ...
CT3 pivots to a dedicated Storage Contracts model to scale its decentralized storage network. The move promises faste...
J.B. Hunt Transport Services heads into tonight's Q2 print trading up about 41% for the year. Analysts will be listen...
The Russell 2000 is on track for its strongest year since 2003, outpacing the S&P 500 as AI infrastructure plays lift...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
When someone says they can promised build their credit, it can sound like a fast fix. But not all credit repair promi...
A fresh Council of Economic Advisers report challenges the net cost figures tied to CFPB rules, arguing higher rates ...